KORU MEDICAL SYSTEMS INC
KRMDNASDAQTrading Snapshot
- Day Range
- $2.99 – $3.05
- 52-Week Range
- $2.99 – $6.61
- Volume
- $3.09B
- Avg Volume
- $3.05B
- Shares Outstanding
- 45.9M
- Next Earnings
- Nov 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $41M
- Last Q Revenue
- $12M
- P/E Ratio
- -78.1
- P/S Ratio
- 3.1x
- EPS (TTM)
- $-0.04
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.6%
Why Investors Own KRMD
- ✓High-growth profile — revenue up +36.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 37% gross margin and 21% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
KORU MEDICAL SYSTEMS INC
KRMD
StockOtter · stockotter.spaceAbout KORU MEDICAL SYSTEMS INC
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
KORU MEDICAL SYSTEMS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift KRMD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
KORU MEDICAL SYSTEMS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.